Evidence map›Paper›PMID 30936836›Full record

ArticleFrontiers in physiology2019

Premature MicroRNA-1 Expression Causes Hypoplasia of the Cardiac Ventricular Conduction System.

Eva Samal, Melissa Evangelista, Giselle Galang, Deepak Srivastava, Yong Zhao, Vasanth Vedantham

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Eva SamalGladstone Institute of Cardiovascular Disease, San Francisco, CA, United States.
Melissa EvangelistaGladstone Institute of Cardiovascular Disease, San Francisco, CA, United States.
Giselle GalangGladstone Institute of Cardiovascular Disease, San Francisco, CA, United States.
Deepak SrivastavaGladstone Institute of Cardiovascular Disease, San Francisco, CA, United States.
Yong ZhaoDepartment of Genetics and Genomic Sciences, Mount Sinai Hospital, New York, NY, United States.
Vasanth VedanthamGladstone Institute of Cardiovascular Disease, San Francisco, CA, United States.
Gladstone Institutes · USUniversity of California, San Francisco · USMount Sinai Hospital · US

Funding

Transcriptional Networks During Cardiac DifferentiationP01HL089707 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI SRIVASTAVA, DEEPAK · 2008 to 2017
$20.4M
CARDIOGENESIS--MOLECULAR MECHANISMSR01HL057181 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI DEEPAK SRIVASTAVA · 1997 to 2026
$14.0M
MIR-1-2 FUNCTION IN CARDIAC CONDUCTION SYSTEM DEVELOPMENT AND MAINTENANCER01HL107376 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZHAO, YONG · 2011 to 2015
$2.0M
Role of MicroRNA-1 in the Cardiac Ventricular Conduction SystemK08HL101989 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VEDANTHAM, VASANTH · 2010 to 2014
$625k
NHLBI NIH HHS K08 HL101989NHLBI NIH HHS P01 HL089707NHLBI NIH HHS R01 HL057181NHLBI NIH HHS R01 HL107376
6 · The paper itself

Abstract

Mammalian cardiac Purkinje fibers (PFs) are specified from ventricular trabecular myocardium during mid-gestation and undergo limited proliferation before assuming their final form. MicroRNA-1 (miR-1), a negative regulator of proliferation, is normally expressed in the heart at low levels during the period of PF specification and outgrowth, but expression rises steeply after birth, when myocardial proliferation slows and postnatal cardiac maturation and growth commence. Here, we test whether premature up-regulation and overexpression of miR-1 during the period of PF morphogenesis influences PF development and function. Using a mouse model in which miR-1 is expressed under the control of the Myh6 promoter, we demonstrate that premature miR-1 expression leads to PF hypoplasia that persists into adulthood, and miR-1 TG mice exhibit delayed conduction through the ventricular myocardium beginning at neonatal stages. In addition, miR-1 transgenic embryos showed reduced proliferation within the trabecular myocardium and embryonic ventricular conduction system (VCS), a source of progenitor cells for the PF. This repression of proliferation may be mediated by direct translational inhibition by miR-1 of the cyclin dependent kinase Cdk6, a key regulator of embryonic myocardial proliferation. Our results suggest that altering the timing of miR-1 expression can regulate PF development, findings which have implications for our understanding of conduction system development and disease in humans.

Indexed as

cardiac conduction systemcardiac developmentcardiac maturationheart blockmicroRNAmiR-1Purkinje fibers

Identifiers

PMID30936836
PMCPMC6431665
OpenAlexW2922220331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.